Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its target price trimmed by Stephens from $27.00 to $25.00 in a research report sent to investors on Thursday morning, Marketbeat.com reports. The brokerage currently has an equal weight rating on the stock. TMCI has been the topic of a number of other reports. Truist Financial decreased […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) shares were up 2.8% during mid-day trading on Monday . The stock traded as high as $17.01 and last traded at $17.00. Approximately 62,683 shares were traded during trading, a decline of 84% from the average daily volume of 388,832 shares. The stock had previously closed […]
Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) had its price target lowered by investment analysts at Truist Financial from $33.00 to $30.00 in a research note issued on Wednesday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective suggests a potential upside of 81.38% from the company’s […]
Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its target price lowered by Stephens from $27.00 to $25.00 in a report issued on Thursday morning, Marketbeat.com reports. The firm currently has an equal weight rating on the stock. Several other brokerages have also recently issued reports on TMCI. Truist Financial dropped their price objective on […]
Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.03, Briefing.com reports. Treace Medical Concepts had a negative net margin of 30.48% and a negative return on equity of 48.57%. The firm […]